PNW vs SLRX · P/E 19, rev $2.61B vs $4.9M cap
Pinnacle West Capital Corp (PNW) versus Salarius Pharmaceuticals Inc (SLRX) — a side-by-side from cached financials, not a winner call.
Pinnacle West Capital Corp (PNW) is a utilities - regulated electric company listed on NYSE.
Salarius Pharmaceuticals Inc (SLRX) is a biotechnology company listed on NASDAQ.
Latest reported PNW revenue for 2026-06-30 was $2.61B. Net income was $215.9M. PNW currently screens at market cap $12.41B and trailing P/E 19.1.
Latest reported SLRX revenue for 2023-03-31 was $0. Net income was -$5.3M. SLRX currently screens at market cap $4.9M.
PNW currently screens at market cap $12.41B and trailing P/E 19.1. SLRX currently screens at market cap $4.9M.
Not investment advice. Open the PNW and SLRX stock pages for the full models.
Not investment advice.